Glucose dysregulation may drive cerebral small vessel disease progression through microstructural brain damage, according to ...
PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results